Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

NCT: NCT04754087 · ACTIVE_NOT_RECRUITING

NCT IDNCT04754087
StatusACTIVE_NOT_RECRUITING
Start Date2021-07-07
Completion2033-12-31
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.

Frequently Asked Questions

What is G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study?

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study is a clinical trial registered under NCT04754087. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04754087?

The current status of NCT04754087 (G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study) is: ACTIVE_NOT_RECRUITING.

When did G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study start?

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study started on 2021-07-07.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.